Literature DB >> 29772545

Autoantibodies against muscarinic acetylcholine receptor M3 in Sjogren's syndrome and corresponding mouse models.

Xinhua Yu1, Gabriela Riemekasten2, Frank Petersen3.   

Abstract

Muscarinic acetylcholine receptor M3 (M3R) is a GPCR on exocrine gland cells involved in fluid secretion. In the last two decades, evidence has been accumulated arguing for a role of autoantibodies (aab) against M3R in the development of Sjögren's syndrome (SS). In this review, we provide an updated overview on this issue and critically discuss the relation between autoimmunity to M3R and SS pathogenesis. Clinical data as well as findings from experimental disease were summarized in categories addressing the presence of aab against M3R in SS patients, the function of anti-M3R aab, the association of aab against M3R with SS-related phenotypes, in vivo pathogenicity of transferred aab against M3R in mice, and mouse models induced via immunization with M3R. Based on these comprehensive data, we propose a hypothetic model for the role of aab against M3R in the pathogenesis of SS.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29772545     DOI: 10.2741/4689

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  8 in total

1.  Antibody deposition on vascular endothelial cells contributes to localized inflammation in salivary glands.

Authors:  Harini Bagavant; Marta Trzeciak; Indranil Biswas; Joanna A Papinska; Katarzyna Cizio; Umesh S Deshmukh
Journal:  J Oral Pathol Med       Date:  2022-07-12       Impact factor: 3.539

2.  Transcutaneous vagus nerve stimulation attenuates autoantibody-mediated cardiovagal dysfunction and inflammation in a rabbit model of postural tachycardia syndrome.

Authors:  Jielin Deng; Hongliang Li; Yankai Guo; Gege Zhang; Hayley Fischer; Stavros Stavrakis; Xichun Yu
Journal:  J Interv Card Electrophysiol       Date:  2022-02-04       Impact factor: 1.759

3.  Immune Response Targeting Sjögren's Syndrome Antigen Ro52 Suppresses Tear Production in Female Mice.

Authors:  Marta Trzeciak; Harini Bagavant; Joanna Papinska; Umesh S Deshmukh
Journal:  Int J Mol Sci       Date:  2018-09-27       Impact factor: 5.923

4.  Aged Sanroque Mice Spontaneously Develop Sjögren's Syndrome-like Disease.

Authors:  Suk San Choi; Eunkyeong Jang; Yeon-Kyung Oh; Kiseok Jang; Mi-La Cho; Sung-Hwan Park; Jeehee Youn
Journal:  Immune Netw       Date:  2019-02-01       Impact factor: 6.303

Review 5.  Innate Immunity and Biological Therapies for the Treatment of Sjögren's Syndrome.

Authors:  Amrita Srivastava; Helen P Makarenkova
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

Review 6.  Purinergic Signaling in Oral Tissues.

Authors:  Mariachiara Zuccarini; Patricia Giuliani; Maurizio Ronci; Francesco Caciagli; Vanni Caruso; Renata Ciccarelli; Patrizia Di Iorio
Journal:  Int J Mol Sci       Date:  2022-07-14       Impact factor: 6.208

7.  Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sjögren's syndrome.

Authors:  Mahmoud Mona; Stefania Mondello; Joon Young Hyon; Wafaa Saleh; Kyudong Han; Hyo-Jung Lee; You-Jung Ha; Eun Ha Kang; Yun Jong Lee; Seunghee Cha
Journal:  Clin Exp Rheumatol       Date:  2020-10-06       Impact factor: 4.473

8.  Autoantibodies against M5-muscarinic and beta1-adrenergic receptors in periodontitis patients.

Authors:  Isabel Scherbaum; Harald Heidecke; Kübra Bunte; Ulrike Peters; Thomas Beikler; Fritz Boege
Journal:  Aging (Albany NY)       Date:  2020-08-28       Impact factor: 5.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.